title: Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
authors.affiliation: Methodist Medical Center of Dallas, Texas.
authors.forename: J
authors.initials: J
authors.lastname: Langley
authors.forename: R
authors.initials: R
authors.lastname: Dickerman
authors.forename: P
authors.initials: P
authors.lastname: Vergne-Marini
authors.forename: J
authors.initials: J
authors.lastname: Williams
authors.forename: S
authors.initials: S
authors.lastname: Jensik
authors.forename: N
authors.initials: N
authors.lastname: Kenyon
authors.forename: J
authors.initials: J
authors.lastname: Anderson
mesh_terms: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016827:CD8 Antigens / Q000276:immunology; D005434:Flow Cytometry / Q000379:methods; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis*; D016030:Kidney Transplantation / Q000276:immunology*; D015166:Monitoring, Immunologic / Q000379:methods; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012016:Reference Values; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016827:CD8 Antigens; D007376:Interleukin-2; D016853:Muromonab-CD3